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Introduction
Depression is reported to affect 6% of adolescents aged from 13 to 18 years [1] with high suicidality, recurrence and chronicity [2, 3] . In adolescents with moderate to severe depression, pharmacological treatment in combination with a psychological therapy is often indicated [4] . As a result of lack of clinical trials in children and adolescents, the off-label use of anti depressant drugs is widespread (about 49% of all antidepressant drugs prescribed) in this population [5] . Among these off-label prescriptions, the use of the selective serotonin reuptake inhibitors (SSRIs) is becoming preferred because of their safer cardiac profiles compared with older medications such as tricyclic antidepressants.
Wolff-Parkinson-White (WPW) syndrome is a macroreentrant arrhythmia with an estimated prevalence of 2-4 per 1000. A significant proportion of cases are found incidentally in asymptomatic patients presenting for routine checkups [6] . Conduction through an accessory pathway may cause preexcitation of the ventricles leading to supraventricular tachycardia, atrial In a dolescents w ith preexisting cardiac disease, depression and anxiety are commonly reported [7] .
SSRIs are generally recommended as first-line psychotropic agents for depressed patients with heart failure [8] and improvement in depression was reported to be asso ciated with improved adherence to cardiovascular drug therapy in adults [9] . However, little is known about the use of SSRIs in y ouths with preexisting cardiac disease, in particular, no cases have been published on the use of SSRIs in adolescents with WPW syndrome.
Case report
We report here the case of a 15-year-old girl who was admitted to our outpatient consultation for a severe depressive episode without psychotic symptoms (F32.2, ICD-10). She had a depressed mood from more than 1 year together with disturbed sleep, loss of energy and of body weight, diminished ability to con centrate and a feeling of worthlessness. Recurrent thoughts of death were present. She scored six on the Clinical Global Impression-Severity (CGI-S) scale, which classified her as "severely ill". As past medical history, she was born prematurely and had been diagnosed with infantile pyloric s tenosis, w hich i s rare i n preterm infants according to the literature [10, 11] . She was treated med- 
Discussion
In this case report, our patient was an adolescent girl presenting severe depressive symptoms before being diagnosed incidentally with WPW syndrome, a macroreentrant arrhythmia d isorder with a n estimated prevalence of 2-4 per 1000. A significant proportion of patients with asymptomatic WPW syndrome are found incidentally when presenting for routine checkups [6] .
Population studies yielded variable but very low incidences of sudden death [12] . Various recommendations on the management of asymptomatic young patients with WPW syndrome have been published [12] . and/or "torsades de pointes" have been reported [13, 14] . However, a recent meta-analysis [14] concluded that QTc pro longation produced by SSRIs (other than citalopram) seemed to be relatively small and was considered to be clinically insignificant for most patients.
Sertraline, compared with other SSRI antidepressants, has been found to be safe for use in adult patients with preexisting cardiac disease [15, 16] and no torsades de pointes has been reported to be associated with single use of sertraline [13] . In children and adolescents, the absence of cardiovascular adverse effects has been reported for sertraline use at doses up to 200 mg [17] .
It has been recommended that a baseline ECG is performed when the patient has a suspicious medical history or related risk factors for arrhythmia, or when the medication to be prescribed is documented to cause prolongation of the QTc interval at therapeutic doses [13] . Although careful risk-benefit analysis is always necessary when antidepressant treatment is proposed, in particular i n infants and a dolescents [9, 15] , an ECG check is not considered necessary before prescribing sertraline in the absence of a known history of cardiac disease or related risk factors [13] . This is in accordance with early reports in adults with preexisting heart disease [15, 16] . However, because of this single case, it is important to emphasise necessary caution, in particular when combining psychotropic treatments, which could lead to severe cardiac events as demonstrated recently with sertraline plus mirtazapine [18] , although single use of mirtazapine has been reported to be efficient in treating depression in an adolescent with preexisting cardiomyopathy and arrhythmia [8] .
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